Caribou

Caribou Biosciences is a biotechnology company that researches and develops gene-edited cell therapies for the treatment of cancer.

Business Model:

Revenue: $10.7M

Employees: 51-200

Detailed Caribou Information

Geographic Data

Caribou headquarters map

Address: 2929 7th Street

City: Berkeley

State: CA

Zip: 94710

Country: US

Financial Info

Stage:

series c

Raised Last:

$115M

Raised Total:

$168M

Metrics

3,313,412Website Global Rank

4,879Website Monthly Traffic

Twitter Followers

Description

Caribou Biosciences is a biotechnology company that researches and develops gene-edited cell therapies for the treatment of cancer.

Contact Phone:
+15109826030

Contact Email:

Caribou went public on 7/23/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/23/2021

IPO Valuation:
$907M

Ticker Symbol:
CRBU

IPO Price:
$16/share

Amount Raised:
$304M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
11/2014 Intellia Therapeutics Series A 0
11/2014 Intellia Therapeutics Series A 0
Announced Date Transaction Number of Investors Money Raised Lead Investors
6/2013 Grant 1 $150k National Science Foundation
National Science Foundation
3/2021 Series C $115M Farallon Capital Management
PFM Health Sciences
Ridgeback Capital Investments
Adage Capital Partners LP
Avego Bioscience Capital
Invus
Janus Henderson Investors
LifeSci Venture Partners
The Leukemia & Lymphoma Society Therapy Acceleration Program
Monashee Investment Management, LLC
Point72
Tekla Capital Management LLC.
Heritage Medical Systems
Maverick Ventures
Pontifax Global Food and Agriculture Technology Fund
9/2014 Venture Round 1 $11.5M Employee Stock Option Fund
3/2021 Series C 20 $115M AbbVie Biotech Ventures
Adage Capital Management
Avego Bioscience Capital
Avidity Partners
Bossanova Investimentos
Farallon Capital Management
Heritage Group
Invus
Janus Henderson Investors
Jesse Robbins
Leukemia &a; Lymphoma Society
LifeSci Venture Partners
Maverick Ventures
Mission BioCapital
Monashee Investment Management
PFM Health Sciences
Point72 Ventures
Pontifax AgTech
Ridgeback Capital
Tekla Capital Management
Aliment Capital
LifeSci Venture Partners
Avego Bioscience Capital
Maverick Ventures
Ridgeback Capital
Farallon Capital Management
Avidity Partners
Janus Henderson Investors
Adage Capital Management
AbbVie Biotech Ventures
Heritage Group
Farallon Capital Management
PFM Health Sciences
Ridgeback Capital
3/2015 Series A $0 Genoa Ventures
The Howard Hughes Medical Institute
U.C. Berkeley
Novartis
Mission Bay Capital
Jennifer Doudna
F-Prime Capital
Genoa Ventures
The Howard Hughes Medical Institute
U.C. Berkeley
Novartis
Mission Bay Capital
Jennifer Doudna
F-Prime Capital
7/2021 IPO $304M
5/2020 Debt $1M U.S. Small Business Administration.
1/2015 Grant -
5/2016 Series B 9 $30M Anterra Capital
Shu Duan
Novartis
Mission Bay Capital
Maverick Ventures
Heritage Group
Genoa Ventures
F-Prime Capital
Aliment Capital
Anterra Capital
3/2015 Series A 7 $11M Genoa Ventures
Genoa Ventures
1/2015 Grant -
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research